Volume 78, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


We evaluated the effectiveness of an overseas pre-departure regimen of five days of albendazole for presumptive treatment of intestinal parasites by examining stool specimens in treated and untreated Montagnard refugees after arrival in the United States. Among 815 refugees evaluated, fully treated refugees had a significantly lower prevalence of helminths (11 [1.4%] of 777), specifically hookworm and , than untreated pregnant women (3 [20%] of 15) ( < 0.001). Multivariate analysis showed that treatment was associated with significantly lower rates of infection with helminths but not protozoa. Post-arrival gastrointestinal symptoms were not associated with findings on stool examination. Our evaluation suggests that although additional studies are needed to determine optimal treatment regimens for intestinal parasites, especially among young children and pregnant women, a five-day course of pre-departure albendazole was effective in reducing helminthic infection in treated refugees.


Article metrics loading...

Loading full text...

Full text loading...



  1. World Health Organization Strategy Development and Monitoring for Parasitic Diseases and Vector Control, 2005. Report of the Third Global Meeting of the Partners for Parasite Control, Deworming for Health and Development. Available at: http://whqlibdoc.who.int/hq/2005/WHO_CDS_CPE_PVC_2005.14.pdf. Accessed August 15, 2007.
  2. Geltman PL, Cochran J, Hedgecock C, 2003. Intestinal parasites among African refugees resettled in Massachusetts and the impact of an overseas pre-departure treatment program. Am J Trop Med Hyg 69 : 657–662.
  3. Lerman D, Barrett-Connor E, Norcross W, 1982. Intestinal parasites in asymptomatic adult Southeast Asian immigrants. J Fam Pract 15 : 443–446.
  4. Peterson MH, Konczyk MR, Amrosino K, Carpenter DF, Wilhelm J, Kocka FE, 2001. Parasitic screening of a refugee population in Illinois. Diagn Microbiol Infect Dis 40 : 75–76.
  5. Sachs WJ, Adair R, Kirchner V, 2000. Enteric parasites in east African immigrants. Minn Med 83 : 25–28.
  6. Catanzaro A, Moser RJ, 1982. Health status of refugees from Vietnam, Laos and Cambodia. JAMA 247 : 1303–1308.
  7. Paxton LA, Slutsker L, Schultz LJ, Luby SP, Meriwether R, Matson P, 1996. Imported malaria in Montagnard refugees settling in North Carolina: implications for prevention and control. Am J Trop Med Hyg 54 : 54–57.
  8. Miller JM, Boyd HA, Ostrowski SR, Cookson ST, Parise ME, Gonzaga PS, 2000. Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections. Am J Trop Med Hyg 62 : 115–121.
  9. Swanson S, Lee B, Mamo B, Smith K, Stauffer W, 2006. Changing Prevalence of Intestinal Parasites among Newly Arrived Southeast Asian and African Refugees after Predeparture Albendazole Treatment—Minnesota, 1993–2004 [Poster]. American Society of Tropical Medicine and Hygiene Meeting, Atlanta, GA, 2006.
  10. Causer LM, Bishop HS, Sharp DJ, Flagg EW, Calderon JF, Keane V, Shah JJ, Macarthur JR, Maloney SA, Cetron MS, Bloland PB, 2005. Rapid malaria screening and targeted treatment of United States-bound Montagnard refugees from Cambodia in 2002. Am J Trop Med Hyg. 72 : 688–693.
  11. Muennig P, Pallin D, Sell RL, Chan MS, 1999. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med 340 : 773–779.
  12. Nazer H, Greer W, Donnelly K, 1993. The need for three stool specimens in routine laboratory examinations for intestinal parasites. Br J Clin Prac 47 : 76–78.
  13. The Medical Letter on Drugs and Therapeutics. Drugs for Parasitic Infections, April 2002.
  14. Wahlquist SP, Williams RM, Bishop H, Addiss DG, Stewart JM, Finton RJ, Juranek DD, Sullivan JJ, 1991. Use of pooled formalin-preserved fecal specimens to detect Giardia lamblia. J Clin Microbiol 1725–1726.
  15. Centers for Disease Control and Prevention. Diagnostic Procedures. Available at: http://www.dpd.cdc.gov/dpdx/HTML/DiagnosticProcedures.htm. Accessed August 15, 2007.
  16. Venkatesan P, 1998. Albendazole. J Antimicrob Chemother 41 : 145–147.
  17. Hall A, Nahar Q, 1993. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans R Soc Trop Med Hyg 87 : 84–86.
  18. Reynoldson JA, Behnke JM, Gracey M, Horton RJ, Spargo R, Hopkins RM, Constantine CC, Gilbert F, Stead C, Hobbs RP, Thompson RC, 1998. Efficacy of albendazole against Giardia and hookworm in a remote Aboriginal community in the north of Western Australia. Acta Trop 71 : 27–44.
  19. Misra PK, Kumar A, Agarwal V, Jagota SC, 1995. A comparative clinical trial of albendazole versus metronidazole in children with giardiasis. Indian Pediatr 32 : 779–782.
  20. Buchwald D, Lam M, Hooton TM, 1995. Prevalence of intestinal parasites and association with symptoms in Southeast Asian refugees. J Clin Pharm Ther Oct 20 : 271–275.
  21. Luoba AI, Wenzel Geissler P, Estambale B, Ouma JH, Alusala D, Ayah R, Mwaniki D, Magnussen P, Friis H, 2005. Earth-eating and reinfection with intestinal helminths among pregnant and lactating women in western Kenya. Trop Med Int Health 10 : 220–227.
  22. Barrett-Connor E, 1982. Direct dollar costs and savings of screening stool examinations for eggs and parasites in adult Southeast Asian refugees. Am J Trop Med Hyg 31 : 466–468.
  23. Anderson JP, Moser RJ, 1985. Parasite screening and treatment among Indochinese refugees, cost-benefit/utility and the general health policy model. JAMA 253 : 2229–2235.
  24. Schistosomiasis and Intestinal Parasites Unit, Division of Control of Tropical Diseases, 1994. Report of the WHO Informal Consultation on Hookworm Infection and Anaemia in Girls and Women. WHO/CTD/SIP/96.1. Available at: http://www.who.int/wormcontrol/documents/publications/en/96-1.pdf. Accessed August 9, 2007.
  25. World Health Organization Strategy Development and Monitoring for Parasitic Diseases and Vector Control (PVC) Prevention, Control and Eradication (CPE) Programme on Communicable Diseases (CDS), 2002. Report of the WHO Informal Consultation on the Use of Praziquantel during Pregnancy/Lactation and Albendazole/Mebendazole in Children under 24 Months. WHO/CDS/CPE/PVC/2002.4. Available at: http://www.who.int/wormcontrol/documents/en/pvc_20024full.pdf. Accessed August 15, 2007.
  26. Bradley M, Horton J, 2001. Assessing the risk of benzimidazole therapy during pregnancy. Trans R Soc Trop Med Hyg 95 : 72–73.
  27. Savioli L, Crompton DW, Neira M, 2003. Use of anthelminthic drugs during pregnancy. Am J Obstet Gynecol 188 : 5–6.
  28. Diav-Citrin O, Shechtman S, Arnon J, Lubart I, Ornoy A, 2003. Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study. Am J Obstet Gynecol 188 : 282–285.
  29. de Silva NR, Sirisena JL, Gunasekera DP, Ismail MM, de Silva HJ, 1999. Effect of mebendazole therapy during pregnancy on birth outcome. Lancet 353 : 1145–1149.
  30. Atukorala TM, de Silva LD, Dechering WH, Dassenaeike TS, Perera RS, 1994. Evaluation of effectiveness of iron-folate supplementation and anthelminthic therapy against anemia in pregnancy—a study in the plantation sector of Sri Lanka. Am J Clin Nutr 60 : 286–292.
  31. Torlesse H, Hodges M, 2000. Anthelminthic treatment and haemoglobin concentrations during pregnancy. Lancet 356 : 1083.
  32. Christian P, Khatry SK, West KP Jr, 2004. Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal. Lancet 364 : 981–983.
  33. D’Alauro F, Lee RV, Pao-In K, Khairallah M, 1985. Intestinal parasites and pregnancy. Obstet Gynecol 166 : 639–643.

Data & Media loading...

  • Received : 15 Aug 2007
  • Accepted : 11 Feb 2008

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error